These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2069032)

  • 1. Human health risk assessment and biological reactive intermediates: hemoglobin binding.
    Ehrenberg L; Tornqvist M
    Adv Exp Med Biol; 1991; 283():641-7. PubMed ID: 2069032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin adducts for in vivo dose monitoring and cancer risk estimation.
    Törnqvist M; Landin HH
    J Occup Environ Med; 1995 Sep; 37(9):1077-85. PubMed ID: 8528715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-Response for Multiple Biomarkers of Exposure and Genotoxic Effect Following Repeated Treatment of Rats with the Alkylating Agents, MMS and MNU.
    Ji Z; LeBaron MJ; Schisler MR; Zhang F; Bartels MJ; Gollapudi BB; Pottenger LH
    Mutagenesis; 2016 May; 31(3):297-308. PubMed ID: 26040483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA.
    Farmer PB; Bailey E; Green JA; Leung CS; Manson MM
    IARC Sci Publ; 1991; (105):71-7. PubMed ID: 1855925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
    Flammang TJ; Yerokun T; Bryant MS; Couch LH; Kirlin WG; Lee KJ; Ogolla F; Ferguson RJ; Talaska G; Hein DW
    J Pharmacol Exp Ther; 1992 Feb; 260(2):865-71. PubMed ID: 1738128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens.
    Doak SH; Jenkins GJ; Johnson GE; Quick E; Parry EM; Parry JM
    Cancer Res; 2007 Apr; 67(8):3904-11. PubMed ID: 17440105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide.
    Walker VE; Fennell TR; Upton PB; MacNeela JP; Swenberg JA
    Environ Health Perspect; 1993 Mar; 99():11-7. PubMed ID: 8319608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of human exposure to carcinogens through DNA and protein adduct determination.
    Farmer PB
    Toxicol Lett; 1995 Dec; 82-83():757-62. PubMed ID: 8597139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adductomic Screening of Hemoglobin Adducts and Monitoring of Micronuclei in School-Age Children.
    Carlsson H; Aasa J; Kotova N; Vare D; Sousa PFM; Rydberg P; Abramsson-Zetterberg L; Törnqvist M
    Chem Res Toxicol; 2017 May; 30(5):1157-1167. PubMed ID: 28398741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents.
    Klapacz J; Pottenger LH; Engelward BP; Heinen CD; Johnson GE; Clewell RA; Carmichael PL; Adeleye Y; Andersen ME
    Mutat Res Rev Mutat Res; 2016; 767():77-91. PubMed ID: 27036068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts.
    Neumann HG
    Int Arch Occup Environ Health; 1988; 60(3):151-5. PubMed ID: 3384479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do dose response thresholds exist for genotoxic alkylating agents?
    Jenkins GJ; Doak SH; Johnson GE; Quick E; Waters EM; Parry JM
    Mutagenesis; 2005 Nov; 20(6):389-98. PubMed ID: 16135536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays.
    Venkatachalam S; Denissenko M; Wani AA
    Carcinogenesis; 1995 Sep; 16(9):2029-36. PubMed ID: 7554050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring of nitropolynuclear aromatic hydrocarbons via protein and DNA adducts.
    el-Bayoumy K; Johnson BE; Roy AK; Upadhyaya P; Partian SJ
    Res Rep Health Eff Inst; 1994 Apr; (64):1-27; discussion 29-37. PubMed ID: 8037891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecule adducts as biomarkers of exposure to environmental mutagens in human populations.
    Ehrenberg L; Granath F; Törnqvist M
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):423-8. PubMed ID: 8781357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dosimetry of alkylating agents: quantitative comparison of genetic effects on the basis of DNA adduct formation.
    van Zeeland AA
    Mutagenesis; 1988 May; 3(3):179-91. PubMed ID: 3137420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of DNA and hemoglobin adducts of fluoranthene after single and multiple exposures.
    Gorelick NJ; Hutchins DA; Tannenbaum SR; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1579-87. PubMed ID: 2670302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonlinear dosimetric model for hemoglobin adduct formation by the neurotoxic agent acrylamide and its genotoxic metabolite glycidamide.
    Calleman CJ; Bergmark E; Stern LG; Costa LG
    Environ Health Perspect; 1993 Mar; 99():221-3. PubMed ID: 8319628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response studies of MeIQx in rat liver and liver DNA at low doses.
    Frantz CE; Bangerter C; Fultz E; Mayer KM; Vogel JS; Turteltaub KW
    Carcinogenesis; 1995 Feb; 16(2):367-73. PubMed ID: 7859370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake, distribution, and formation of hemoglobin and DNA adducts after inhalation of C2-C8 1-alkenes (olefins) in the rat.
    Eide I; Hagemann R; Zahlsen K; Tareke E; Törnqvist M; Kumar R; Vodicka P; Hemminki K
    Carcinogenesis; 1995 Jul; 16(7):1603-9. PubMed ID: 7614695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.